Page last updated: 2024-11-02

pentoxifylline and Polycystic Ovarian Syndrome

pentoxifylline has been researched along with Polycystic Ovarian Syndrome in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The letrozole-induced PCOs were characterized by irregular cycles, high incidence of subcapsular ovarian cysts with diminished or scant granulosa cell layers, increased number of atretic preantral and antral follicles, and absence of CL."1.42Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary. ( Abdollahi, M; Baeeri, M; Gooshe, M; Mansoori, P; Rezvanfar, MA; Saadat, S; Saeedi, S; Shojaei Saadi, HA, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rezvanfar, MA1
Saadat, S1
Shojaei Saadi, HA1
Mansoori, P1
Saeedi, S1
Gooshe, M1
Baeeri, M1
Abdollahi, M1

Other Studies

1 other study available for pentoxifylline and Polycystic Ovarian Syndrome

ArticleYear
Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary.
    Theriogenology, 2015, Apr-01, Volume: 83, Issue:6

    Topics: Animals; Aromatase Inhibitors; Biomarkers; Female; Letrozole; Nitriles; Oxidative Stress; Pentoxifyl

2015